Interim Results of the PROMISE I Trial to Investigate the LimFlow System of Percutaneous Deep Vein Arterialization for the Treatment of Critical Limb Ischemia.

CONCLUSION: pDVA using the LimFlow system is a novel approach for treating patients with no-option CLI and may reduce amputation in this population for whom it would otherwise be considered inevitable. Initial findings from this early feasibility trial are promising and additional study is warranted.
PMID: 30819976 [PubMed - in process]

Source: The Journal of Invasive Cardiology - March 5, 2019 Category: Cardiology Tags: J Invasive Cardiol Source Type: research